Essa Pharma Inc. (EPIX) NASDAQ
$3.05 0.06 (2.01%)
Market Cap: $134.48M
As of 06/02/23 04:30 PM EDT. Market closed.
Essa Pharma Inc. (EPIX)
NASDAQ
$3.05
0.06 (2.01%)
Market Cap: $134.48M
As of 06/02/23 04:30 PM EDT. Market closed.
ESSA is a clinical-stage pharmaceutical company focused on developing novel and proprietary therapies for the treatment of patients with prostate ... read more
ESSA is a clinical-stage pharmaceutical company focused on developing novel and proprietary therapies for the treatment of patients with prostate cancer. read less
COMPANY PROFILE
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
Full Time Employees
50
Address
.
PRICE CHART FOR ESSA PHARMA INC
From:
To:
NEWS
KEY STATS
Open
$2.95
Previous Close
$2.99
Days Range
$2.94 - $3.05
52 week range
$1.40 - $5.38
Volume
20,583
Avg. Volume (30 days)
40,696
Market Cap
$134.48M
Dividend Yield
0.00%
P/E
-
Shares Outstanding
44,092,374
Open
$2.95
Previous Close
$2.99
Days Range
$2.94 - $3.05
52 week range
$1.40 - $5.38
Volume
20,583
Avg. Volume (30 days)
40,696
Market Cap
$134.48M
Dividend Yield
0.00%
P/E
-
Shares Outstanding
44,092,374
Open in: 
Open in:
INSIDER TRANSACTIONS FOR ESSA PHARMA INC
| Owner | Relationship | Date | Transaction | Cost | # Shares | Value($) | Total Shares | Form 4 |
| Parkinson David Ross | Chief Executive Officer | Dec 30, 2022 | Buy | $2.60 | 3,067 | 7,974 | 56,542 | Jan 05, 2023, 06:18 PM |
| Parkinson David Ross | Chief Executive Officer | Dec 22, 2022 | Buy | $2.39 | 21,367 | 51,067 | 53,475 | Jan 05, 2023, 06:18 PM |
| BERGER FRANKLIN M | Director | Dec 21, 2022 | Sale | $2.41 | 72,223 | 174,401 | 718,738 | Jan 05, 2023, 03:41 PM |
| BERGER FRANKLIN M | Director | Dec 20, 2022 | Sale | $2.53 | 43,617 | 110,351 | 756,627 | Jan 05, 2023, 03:41 PM |
| BERGER FRANKLIN M | Director | Dec 16, 2022 | Sale | $2.67 | 50,000 | 133,500 | 800,244 | Jan 05, 2023, 03:41 PM |
| BERGER FRANKLIN M | Director | Dec 15, 2022 | Sale | $2.88 | 82,000 | 235,800 | 900,244 | Jan 05, 2023, 03:41 PM |
| BERGER FRANKLIN M | Director | Dec 14, 2022 | Sale | $3.00 | 25,000 | 75,000 | 932,244 | Jan 05, 2023, 03:41 PM |
| Wood David S. | Chief Financial Officer | Dec 30, 2022 | Buy | $2.60 | 8,302 | 21,585 | 33,343 | Jan 05, 2023, 03:07 PM |
| BIOTECH GROWTH N V | 10% Owner | Oct 27, 2022 | Buy | $4.50 | 500,000 | 2,251,100 | 7,879,583 | Oct 28, 2022, 02:57 PM |
| BIOTECH GROWTH N V | 10% Owner | Oct 26, 2022 | Buy | $3.98 | 1,500,000 | 5,968,500 | 7,379,583 | Oct 28, 2022, 02:57 PM |
| BIOTECH GROWTH N V | 10% Owner | Jul 18, 2022 | Buy | $3.16 | 300,000 | 946,740 | 5,879,583 | Jul 20, 2022, 03:21 PM |
| BIOTECH GROWTH N V | 10% Owner | Jul 15, 2022 | Buy | $3.13 | 241,665 | 756,798 | 5,579,583 | Jul 18, 2022, 12:48 PM |
| BIOTECH GROWTH N V | 10% Owner | Jul 14, 2022 | Buy | $2.79 | 347,204 | 969,428 | 5,337,918 | Jul 18, 2022, 12:48 PM |
| Parkinson David Ross | Chief Executive Officer | Jun 30, 2022 | Buy | $2.96 | 4,887 | 14,456 | 32,108 | Jul 05, 2022, 01:39 PM |
| BIOTECH GROWTH N V | 10% Owner | Apr 27, 2022 | Sale | $5.85 | 25,100 | 146,925 | 4,990,714 | Apr 28, 2022, 12:28 PM |
| BIOTECH GROWTH N V | 10% Owner | Aug 18, 2021 | Buy | $8.88 | 250,000 | 2,218,800 | 5,015,814 | Aug 20, 2021, 12:43 PM |
| BERGER FRANKLIN M | Director | Feb 22, 2021 | Buy | $27.00 | 57,000 | 1,539,000 | 957,244 | Mar 04, 2021, 06:47 PM |
| BERGER FRANKLIN M | Director | Dec 03, 2020 | Option Exercise | $3.64 | 42,207 | 153,701 | 900,244 | Jan 11, 2021, 04:42 PM |
Load More Insider Transactions
Buy
Sale
Option Exercise
| Owner | Relationship | Date | Value($) |
| Parkinson David Ross | Chief Executive Officer | 12/30/2022 | 7,974 |
| Parkinson David Ross | Chief Executive Officer | 12/22/2022 | 51,067 |
| BERGER FRANKLIN M | Director | 12/21/2022 | 174,401 |
| BERGER FRANKLIN M | Director | 12/20/2022 | 110,351 |
| BERGER FRANKLIN M | Director | 12/16/2022 | 133,500 |
| BERGER FRANKLIN M | Director | 12/15/2022 | 235,800 |
| BERGER FRANKLIN M | Director | 12/14/2022 | 75,000 |
| Wood David S. | Chief Financial Officer | 12/30/2022 | 21,585 |
| BIOTECH GROWTH N V | 10% Owner | 10/27/2022 | 2,251,100 |
| BIOTECH GROWTH N V | 10% Owner | 10/26/2022 | 5,968,500 |
| BIOTECH GROWTH N V | 10% Owner | 07/18/2022 | 946,740 |
| BIOTECH GROWTH N V | 10% Owner | 07/15/2022 | 756,798 |
| BIOTECH GROWTH N V | 10% Owner | 07/14/2022 | 969,428 |
| Parkinson David Ross | Chief Executive Officer | 06/30/2022 | 14,456 |
| BIOTECH GROWTH N V | 10% Owner | 04/27/2022 | 146,925 |
| BIOTECH GROWTH N V | 10% Owner | 08/18/2021 | 2,218,800 |
| BERGER FRANKLIN M | Director | 02/22/2021 | 1,539,000 |
| BERGER FRANKLIN M | Director | 12/03/2020 | 153,701 |
Load More Insider Transactions
FUNDS WITH A POSITION IN ESSA PHARMA INC
| Fund | # Shares Owned | % of Portfolio | % Change | Investing Style |
|---|---|---|---|---|
| ORBIMED ADVISORS LLC | 1,198,337 | 0.07% | 228.04% | Other |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 1,042,531 | 0.00694% | No change | Other |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 264,571 | 0.01% | No change | Growth |
| D. E. SHAW & CO., INC. | 172,221 | 0.00055% | -31.22% | Other |
| RENAISSANCE TECHNOLOGIES LLC | 34,624 | 0.00012% | Exited | Other |
| GEODE CAPITAL MANAGEMENT, LLC | 19,039 | 0.00001% | No change | Other |
| BLACKROCK INC. | 2,261 | 0% | New | Other |
CHANGE IN SHARES OUTSTANDING FOR ESSA PHARMA INC
STOCK BUYBACKS FOR ESSA PHARMA INC
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
Load More
Period of Report: 03/31/2023
10-K/10-Q Filings: View
Previous Period
% Change in Shares
Quarter
12/31/2022
0.02%
1Q
09/30/2022
0.10%
2Q
06/30/2022
0.13%
3Q
03/31/2022
0.17%
4Q
12/31/2021
0.21%
5Q
09/30/2021
14.56%
6Q
06/30/2021
19.35%
7Q
03/31/2021
26.32%
8Q
12/31/2020
32.21%
9Q
Load More